443 related articles for article (PubMed ID: 30323584)
1. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system.
Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F
Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584
[TBL] [Abstract][Full Text] [Related]
2. [Preparation and
Huang AH; Han SP; Lu YP; Ma R; Zheng HS; Li FZ
Zhongguo Zhong Yao Za Zhi; 2018 Apr; 43(8):1618-1625. PubMed ID: 29751708
[TBL] [Abstract][Full Text] [Related]
3. iRGD and TGN co-modified PAMAM for multi-targeted delivery of ATO to gliomas.
Shi X; Ma R; Lu Y; Cheng Y; Fan X; Zou J; Zheng H; Li F; Piao JG
Biochem Biophys Res Commun; 2020 Jun; 527(1):117-123. PubMed ID: 32446354
[TBL] [Abstract][Full Text] [Related]
4. Angiopep-2-Conjugated "Core-Shell" Hybrid Nanovehicles for Targeted and pH-Triggered Delivery of Arsenic Trioxide into Glioma.
Tao J; Fei W; Tang H; Li C; Mu C; Zheng H; Li F; Zhu Z
Mol Pharm; 2019 Feb; 16(2):786-797. PubMed ID: 30620881
[TBL] [Abstract][Full Text] [Related]
5. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q
Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456
[TBL] [Abstract][Full Text] [Related]
6. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration.
Xu X; Li J; Han S; Tao C; Fang L; Sun Y; Zhu J; Liang Z; Li F
Eur J Pharm Sci; 2016 Jun; 88():178-90. PubMed ID: 26965003
[TBL] [Abstract][Full Text] [Related]
7. RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma.
Zhang L; Zhu S; Qian L; Pei Y; Qiu Y; Jiang Y
Eur J Pharm Biopharm; 2011 Oct; 79(2):232-40. PubMed ID: 21496485
[TBL] [Abstract][Full Text] [Related]
8. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
Li Y; He H; Jia X; Lu WL; Lou J; Wei Y
Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698
[TBL] [Abstract][Full Text] [Related]
9. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
[TBL] [Abstract][Full Text] [Related]
10. PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors.
He H; Li Y; Jia XR; Du J; Ying X; Lu WL; Lou JN; Wei Y
Biomaterials; 2011 Jan; 32(2):478-87. PubMed ID: 20934215
[TBL] [Abstract][Full Text] [Related]
11. Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer.
Gao S; Li J; Jiang C; Hong B; Hao B
Drug Des Devel Ther; 2016; 10():1-11. PubMed ID: 26719669
[TBL] [Abstract][Full Text] [Related]
12. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma.
Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C
Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333
[TBL] [Abstract][Full Text] [Related]
13. [Preparation and in vitro evaluation of borneol and folic acid co-modified doxorubicin loaded PAMAM drug delivery system].
Li JJ; Guo MM; Han SP; Sun Y; Fei WD; Xu XI; Li FZ
Yao Xue Xue Bao; 2015 Jul; 50(7):899-905. PubMed ID: 26552154
[TBL] [Abstract][Full Text] [Related]
14. Novel Strategy of Gene Delivery System Based on Dendrimer Loaded Recombinant Hirudine Plasmid for Thrombus Targeting Therapy.
Chen J; Lu Y; Cheng Y; Ma R; Zou J; Zheng H; Wang R; Zhu Z; Li F
Mol Pharm; 2019 Apr; 16(4):1648-1657. PubMed ID: 30802064
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration.
Li J; Zhang X; Wang M; Li X; Mu H; Wang A; Liu W; Li Y; Wu Z; Sun K
Int J Pharm; 2016 Mar; 501(1-2):112-23. PubMed ID: 26828670
[TBL] [Abstract][Full Text] [Related]
16. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
[TBL] [Abstract][Full Text] [Related]
17. Angiopep-2-modified calcium arsenite-loaded liposomes for targeted and pH-responsive delivery for anti-glioma therapy.
Xu H; Li C; Wei Y; Zheng H; Zheng H; Wang B; Piao JG; Li F
Biochem Biophys Res Commun; 2021 Apr; 551():14-20. PubMed ID: 33714754
[TBL] [Abstract][Full Text] [Related]
18. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
[TBL] [Abstract][Full Text] [Related]
19. 'Prodrug-Like' Acetylmannosamine Modified Liposomes Loaded With Arsenic Trioxide for the Treatment of Orthotopic Glioma in Mice.
Wang N; Zhang W; Hu D; Jiang L; Liu X; Tang S; Zhou X; Liu T; Tang X; Chai Y; Li M; Peng H; Du Z
J Pharm Sci; 2020 Sep; 109(9):2861-2873. PubMed ID: 32534027
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide induces apoptosis and the formation of reactive oxygen species in rat glioma cells.
Sun Y; Wang C; Wang L; Dai Z; Yang K
Cell Mol Biol Lett; 2018; 23():13. PubMed ID: 29610575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
